Literature DB >> 3893827

Nocardia asteroides sepsis of the knee.

R D Wilkerson, D C Taylor, S M Opal, W W Curl.   

Abstract

Nocardia asteroides as an infecting agent has been an increasingly identified pathogen in humans, especially in immunosuppressed hosts. The Nocardia organisms as a cause of septic arthritis have been very unusual and in all previously reported cases have occurred in immunosuppressed patients. This is a report of two additional patients, one of whom has had no history of immunosuppression either before infection or subsequent to treatment and resolution of the infection. The second is a case of a questionably immunosuppressed patient with Nocardia asteroides septic arthritis. These cases reemphasize the importance of performing not only the most common aerobic and anaerobic bacterial cultures but also fungal and acid-fast bacilli cultures for early identification of less common organisms and for the initiation of appropriate therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893827

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Septic arthritis due to Nocardia caviae.

Authors:  N P Torre; B K Kim
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

Review 2.  Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.

Authors:  Barbara A Brown-Elliott; June M Brown; Patricia S Conville; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 3.  Nocardia species: host-parasite relationships.

Authors:  B L Beaman; L Beaman
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

Review 4.  Nocardia Arthritis: 3 Cases and Literature Review.

Authors:  Hélène Chaussade; David Lebeaux; Guillaume Gras; Emilie Catherinot; Blandine Rammaert; Sylvain Poiree; Hervé Lecuyer; Valérie Zeller; Louis Bernard; Olivier Lortholary
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.